David Plowchalk

David Plowchalk

UNVERIFIED PROFILE

Are you David Plowchalk?   Register this Author

Register author
David Plowchalk

David Plowchalk

Publications by authors named "David Plowchalk"

Are you David Plowchalk?   Register this Author

10Publications

200Reads

17Profile Views

Novel, selective vitamin D analog suppresses parathyroid hormone in uremic animals and postmenopausal women.

Am J Nephrol 2014 17;39(6):476-83. Epub 2014 May 17.

Department of Biochemistry, University of Wisconsin-Madison, and Deltanoid Pharmaceuticals, Inc.,Madison, Wisc., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000362846DOI Listing
March 2015

Drug metabolites as cytochrome p450 inhibitors: a retrospective analysis and proposed algorithm for evaluation of the pharmacokinetic interaction potential of metabolites in drug discovery and development.

Drug Metab Dispos 2013 Dec 21;41(12):2047-55. Epub 2013 Jun 21.

Pharmacokinetics, Dynamics and Metabolism-New Chemical Entities (E.C., L.L., R.S.O., S.T.) and Clinical Pharmacology (D.R.P.), Pfizer Inc., Groton, Connecticut; and Pharmacokinetics, Dynamics and Metabolism-New Chemical Entities, Pfizer Inc., Cambridge, Massachusetts (A.S.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/dmd.113.052241DOI Listing
December 2013

Prediction of drug clearance in a smoking population: modeling the impact of variable cigarette consumption on the induction of CYP1A2.

Eur J Clin Pharmacol 2012 Jun 19;68(6):951-60. Epub 2012 Jan 19.

Clinical Pharmacology, Primary Care BU, Pfizer Inc., 445 Eastern Point Road, Groton, CT 06340, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-011-1189-yDOI Listing
June 2012

The sulfonylurea glipizide does not inhibit ischemic preconditioning in anesthetized rabbits.

Cardiovasc Drugs Ther 2005 Oct;19(5):337-46

Department of Cardiovascular, Metabolic and Endocrine Diseases, Pfizer Global Research and Development, Pfizer Inc., Groton, CT 06340, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10557-005-4970-2DOI Listing
October 2005

Development of a physiologically based pharmacokinetic model for estradiol in rats and humans: a biologically motivated quantitative framework for evaluating responses to estradiol and other endocrine-active compounds.

Toxicol Sci 2002 Sep;69(1):60-78

DuPont Haskell Laboratory for Health and Biomedical Sciences, Newark, Delaware 19714. The K.S. Crump Group, Inc., ICF Consulting, Research Triangle Park, North Carolina 27709, USA.

View Article

Download full-text PDF

Source
http://toxsci.oxfordjournals.org/content/69/1/60.full.pdf
Web Search
http://dx.doi.org/10.1093/toxsci/69.1.60DOI Listing
September 2002